UCLA: VCA Program Update Erin Core, RN, BSN, CCTC Coordinator, Reconstructive Transplantation

Embed Size (px)

Citation preview

  • Slide 1
  • UCLA: VCA Program Update Erin Core, RN, BSN, CCTC Coordinator, Reconstructive Transplantation
  • Slide 2
  • UNOS/OPTN Oversight VCAs should be included within the definition of organs covered by the OPTN Final Rule (42 CFR part 121) and section 301 of NOTA Planning and implementation began in earnest in 2014 for UNOS/OPTN oversight
  • Slide 3
  • VCA participation as of February 2014 28 VCA transplant recipients had been transplanted at 11 different transplant centers 9 patients at 6 different transplant centers were waiting for a VCA transplant UNOS/OPTN Oversight
  • Slide 4
  • As of August 29, 2014, there were 15 OPTN approved VCA transplant hospitals and seven VCA candidates registered on the OPTN waiting list. OPTN changed the membership criteria to delineate specific VCA transplant programs to upper limb, face, lower limb, and abdominal wall.
  • Slide 5
  • UNOS/OPTN VCA Criteria That is vascularized and requires blood flow by surgical connection of blood vessels to function after transplantation Containing multiple tissue types Recovered from a human donor as an anatomical/structural unit Transplanted into a human recipient as an anatomical/structural unit
  • Slide 6
  • UNOS/OPTN VCA Criteria (continued) Minimally manipulated (i.e., processing that does not alter the original relevant characteristics of the organ relating to the organ's utility for reconstruction, repair, or replacement) For homologous use (the replacement or supplementation of a recipient's organ with an organ that performs the same basic function or functions in the recipient as in the donor)
  • Slide 7
  • UNOS/OPTN VCA Criteria (continued) Not combined with another article such as a device Susceptible to ischemia and, therefore, only stored temporarily and not cryopreserved Susceptible to allograft rejection, generally requiring immunosuppression that may increase infectious disease risk to the recipient
  • Slide 8
  • UNOS/OPTN VCA Program Criteria A reconstructive surgical director and medical director identified as responsible VCA program staff VCA program must be at a transplant hospital Required to have a functioning solid organ transplant program Requires a letter from the programs local OPO
  • Slide 9
  • UNOS/OPTN VCA Program Criteria (continued) A letter of intent from the institution signed by (chief administrative officer, a reconstructive surgeon, and a transplant specialist) designated as responsible for the VCA transplant program would serve as the application for a VCA program
  • Slide 10
  • UNOS/OPTN VCA Waitlist Management Transplant programs will register their VCA candidates in a document that they will securely transmit to UNOS UNOS will compile all of the candidate registrations into a master list which would be distributed to OPOs OPOs will match VCA donors to candidates using the master list
  • Slide 11
  • UNOS/OPTN VCA Waitlist Management (continued) If an OPO identifies a VCA donor that is suitable for more than one candidate from the master list, allocation will first be offered to regional candidates If the organ is not accepted regionally, allocation will be offered to national candidates Within each classification, waiting time will be used as the tie breaker between candidates
  • Slide 12
  • UCLA VCA Programs UCLA Reconstructive Transplant Programs - Hand(s)/Upper Extremity(extremities) - Face - Abdominal Wall (always with liver or intestine transplantation)
  • Slide 13
  • Developed in conjunction with OneLegacy Consent for organ donation Second consent for VCA ABO compatible Similar size, age, and skin tone/hair match No identifying marks on the tissue being transplanted Introduction of PHS High risk donor No DCD donors No malignancies No trauma or musculoskeletal disorders of the affected structure(s) Assessment of social/criminal history UCLA Donor Selection Criteria
  • Slide 14
  • Policies and procedures written to meet existing solid organ standards set by CMS and UNOS Provide prosthetic at time of donation for limb and facial donation UCLA Policies and Procedures
  • Slide 15
  • UCLA VCA Matching Criteria Skin Tone match and acceptable range Relative Age Size Hair quality and quantity General features: height, weight, hair color, eye color, ethnicity
  • Slide 16
  • UCLA Upper Limb Transplantation Standard of care prior to VCA is prosthetics Candidates feel prosthetics do not provide adequate replacement Currently two candidates in screening Female bilateral upper extremity one below and one above the elbow Male unilateral above the elbow
  • Slide 17
  • UCLA Face Transplantation Restore function oral competency, respiratory system, and communication Regain identity and societal acceptance Reestablish non-verbal communication Recover protection of intact craniofacial structures
  • Slide 18
  • Standard of Care Prior to VCA
  • Slide 19
  • Univ. of Maryland Full Face Transplant
  • Slide 20
  • UCLA Face Candidate
  • Slide 21
  • Slide 22
  • Slide 23
  • UCLA Abdominal Wall Transplantation Currently finalizing protocols and planning Identified multivisceral candidate Candidates are unable to undergo life- saving transplant of multivisceral organs without the abdominal wall Current candidate unable to receive intestine, liver, and pancreas due to inadequate soft tissue coverage
  • Slide 24
  • UCLA Abdominal Wall Transplantation
  • Slide 25
  • Slide 26
  • Exponential growth of VCA programs across US necessitated standardization of practices, oversight, and a formal allocation mechanism Keys to success are collaboration and communication between the transplant programs, OPO, and extended care provider network Research with each and every transplant performed Conclusions
  • Slide 27
  • Questions?
  • Slide 28
  • References 1.Glazier, A. Regulatory Face-Off: What agency should oversee face transplants? American Journal of Transplantation 2008; 8: 1393-1395 2. Levi D, Tzakis A, Kato T, Madaraga J, Mittal N, Nery J, Nishida S, Ruiz P. Transplantation of Abdominal Wall. The Lancet Vol361 2003. 3. Petruzzo P, Lanzetta M, Dubernard JM, Landin L, Cavadas P, Margreiter R, Schneeberger S, Breidenbach W, Kaufman C, Jablecki J, Schuind F, Dumontier C. The International Registry on Hand and Composite Tissue Transplantation. Transplantation 2010; 90: 1590 4. Implement the OPTN's Oversight of Vascularized Composite Allografts (VCAs). http://optn.transplant.hrsa.gov/governance/public-comment/implement-the-optns-oversight- of-vascularized-composite-allografts-vcas/ Retrieved March 9, 2015 http://optn.transplant.hrsa.gov/governance/public-comment/implement-the-optns-oversight-